Tools to Improve Medication Continuity in Adolescents With ADHD

Study Overview
=================
Brief Summary
-----------------
Medication is an efficacious treatment strategy for adolescents with attention-deficit/hyperactivity disorder (ADHD), however use significantly declines during adolescence when the consequences of ADHD are most severe (e.g. dropping out of school, delinquency, etc.). The Unified Theory of Behavior Change (UTBC) has been proposed as a conceptual model to explain the mechanism underlying ADHD medication adherence and to guide the development of interventions to improve the continuity of treatment. The UTBC is a well-established and empirically tested model that identifies factors that influence an individual's intention to perform a behavior as well as factors that influence whether a behavior is actually carried out. Indeed, the research team's preliminary data support the relevance of pre-intention factors and implementation factors for medication continuity among adolescents with ADHD. Currently, no evidence-based interventions target medication continuity for adolescents with ADHD. The objective of this study is to test a multi-component intervention that systematically identifies and targets aspects of the UTBC model most relevant for each adolescent with poor ADHD medication continuity. The central hypothesis is that the tailored intervention will support ADHD medication continuity. The study will conduct an open label trial among adolescents with poor medication continuity to test whether the intervention engages the mechanism underlying medication continuity and improves outcomes.

Official Title
-----------------
Web Based Tools to Improve Medication Continuity in Adolescents With ADHD

Conditions
-----------------
Attention Deficit Hyperactivity Disorder

Intervention / Treatment
-----------------
* Other: Mehealth for ADHD software with medication continuity tools
* Other: Mehealth for ADHD software without medication continuity tools


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: First prescribed ADHD medicine more than one year prior to enrollment Registered on myADHDportal.com at practice participating in study Filled at least one prescription for a stimulant medication in the past year Exclusion Criteria: More than 80% of days covered with medicine over past one year Poor understanding level: The participant and parent cannot understand or follow instructions given in the study.

Ages Eligible for Study
-----------------
Minimum Age: 11 Years
Maximum Age: 15 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Intervention Model: Single Group Assignment
Interventional Model Description: Open Label Trial
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention<br>All adolescent/parent dyads enrolled at each practice will have access to the meHealth for ADHD software without medication continuity tools prior to being given access to the medication continuity tools. | Other: Mehealth for ADHD software with medication continuity tools<br>* Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommends tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.<br>Other: Mehealth for ADHD software without medication continuity tools<br>* The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) a communication feature that allows parents, teachers, and pediatricians to communicate with each other; 6) an online pediatrician report card; and 7) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Proportion of days covered with medicine | This will be calculated based pharmacy dispensing records | An average of 4 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Fidelity to intended use of intervention components | Proportion of intervention components completed relative to the components that were recommended by the portal based on adolescent/parent responses to the assessment battery. | An average of 4 months | 
| Change in pre-intention factors of Unified Theory of Behavior Change influencing medication continuity | Adolescent and parent self-report on a 7 point scale. Individual items measure specific attitudes, subjective norms, and perceived behavioral control. Higher scores indicate a stronger intention to perform the behavior | At baseline and 4 months later | 
| Change in intention to take/give ADHD medicine regularly | Adolescent and parent self-report on 7 point scale. Higher scores indicate a stronger intention. | At baseline and 4 months later | 
| Change in adolescent report of medication barriers | Adolescent self-report on the 17 item Adolescent Medication Barriers Scale using 5 point Likert scale. Minimum score = 17, Maximum score = 85. Higher score means more barriers. | At baseline and 4 months later | 
| Change in parent report of medication barriers | Parent self-report on the 16 item Parent Medication Barriers Scale using 5 point Likert scale. Minimum score = 16, Maximum score = 80. Higher score means more barriers. | At baseline and 4 months later | 
| Change in medication diversion | Adolescent self-report of the number of occasions of giving away, trading, or selling ADHD medicine to someone for whom it was not prescribed. | At baseline and 4 months later | 
| Change in Decision Making Involvement Scale | Adolescent and Parent self-report. The scale contains the following subscales: Child Seek (e.g. child asks for an opinion or information from the parent), Child Express (e.g. child expresses an opinion or information to the parent), Parent Seek (e.g. parent asks for an opinion or information from child), Parent Express (e.g. parent expresses advice, an opinion, or information to the child), and Joint/Options (e.g. negotiation and brainstorming between child and parent). Each subscale produces a score which ranges from 1 to 4 with higher scores indicating more of that behavior. | At baseline and 4 months later |